Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 May;50(5):331–336. doi: 10.1136/ard.50.5.331

Small intestinal mucosal protection mechanisms and their importance in rheumatology.

S O'Mahony 1, A Ferguson 1
PMCID: PMC1004423  PMID: 2042991

Full text

PDF
336

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjarnason I., Hopkinson N., Zanelli G., Prouse P., Smethurst P., Gumpel J. M., Levi A. J. Treatment of non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1990 Jul;31(7):777–780. doi: 10.1136/gut.31.7.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bjarnason I., Peters J. Helping the mucosa make sense of macromolecules. Gut. 1987 Sep;28(9):1057–1061. doi: 10.1136/gut.28.9.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bjarnason I., Peters T. J. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut. 1989 Nov;30(Spec No):22–28. doi: 10.1136/gut.30.spec_no.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bjarnason I., Price A. B., Zanelli G., Smethurst P., Burke M., Gumpel J. M., Levi A. J. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology. 1988 Apr;94(4):1070–1074. doi: 10.1016/0016-5085(88)90568-9. [DOI] [PubMed] [Google Scholar]
  5. Bjarnason I., Smethurst P., Fenn C. G., Lee C. E., Menzies I. S., Levi A. J. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci. 1989 Mar;34(3):407–411. doi: 10.1007/BF01536263. [DOI] [PubMed] [Google Scholar]
  6. Bjarnason I., Williams P., Smethurst P., Peters T. J., Levi A. J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986 Nov;27(11):1292–1297. doi: 10.1136/gut.27.11.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bjarnason I., Williams P., So A., Zanelli G. D., Levi A. J., Gumpel J. M., Peters T. J., Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet. 1984 Nov 24;2(8413):1171–1174. doi: 10.1016/s0140-6736(84)92739-9. [DOI] [PubMed] [Google Scholar]
  8. Bjarnason I., Zanelli G., Prouse P., Smethurst P., Smith T., Levi S., Gumpel M. J., Levi A. J. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987 Sep 26;2(8561):711–714. doi: 10.1016/s0140-6736(87)91075-0. [DOI] [PubMed] [Google Scholar]
  9. Bjarnason I., Zanelli G., Smith T., Prouse P., Williams P., Smethurst P., Delacey G., Gumpel M. J., Levi A. J. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987 Sep;93(3):480–489. doi: 10.1016/0016-5085(87)90909-7. [DOI] [PubMed] [Google Scholar]
  10. Brandtzaeg P., Baklien K. Immunoglobulin-producing cells in the intestine in health and disease. Clin Gastroenterol. 1976 May;5(2):251–269. [PubMed] [Google Scholar]
  11. Brandtzaeg P., Baklien K. Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol Suppl. 1976;36:1–45. [PubMed] [Google Scholar]
  12. Brandtzaeg P., Korsrud F. R. Significance of different J chain profiles in human tissues: generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue. Clin Exp Immunol. 1984 Dec;58(3):709–718. [PMC free article] [PubMed] [Google Scholar]
  13. Brandtzaeg P. The secretory immune system of lactating human mammary glands compared with other exocrine organs. Ann N Y Acad Sci. 1983 Jun 30;409:353–382. doi: 10.1111/j.1749-6632.1983.tb26883.x. [DOI] [PubMed] [Google Scholar]
  14. Colten H. R., Bienenstock J. Lack of C3 activation through classical or alternate pathways by human secretory IgA anti blood group A antibody. Adv Exp Med Biol. 1974;45(0):305–308. doi: 10.1007/978-1-4613-4550-3_36. [DOI] [PubMed] [Google Scholar]
  15. Cooper R., Fraser S. M., Sturrock R. D., Gemmell C. G. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1988 May 21;296(6634):1432–1434. doi: 10.1136/bmj.296.6634.1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Eastmond C. J. Gram-negative bacteria and B27 disease. Br J Rheumatol. 1983 Nov;22(4 Suppl 2):67–74. doi: 10.1093/rheumatology/xxii.suppl_2.67. [DOI] [PubMed] [Google Scholar]
  17. Ebringer A. The relationship between Klebsiella infection and ankylosing spondylitis. Baillieres Clin Rheumatol. 1989 Aug;3(2):321–338. doi: 10.1016/s0950-3579(89)80024-x. [DOI] [PubMed] [Google Scholar]
  18. Ebringer R. W., Cawdell D. R., Cowling P., Ebringer A. Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease. Ann Rheum Dis. 1978 Apr;37(2):146–151. doi: 10.1136/ard.37.2.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Elson C. O. Induction and control of the gastrointestinal immune system. Scand J Gastroenterol Suppl. 1985;114:1–15. doi: 10.3109/00365528509093764. [DOI] [PubMed] [Google Scholar]
  20. Franssen M. J., van de Putte L. B., Gribnau F. W. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis. 1985 Nov;44(11):766–771. doi: 10.1136/ard.44.11.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Freter R. Mechanism of Action of Intestinal Antibody in Experimental Cholera II. Antibody-Mediated Antibacterial Reaction at the Mucosal Surface. Infect Immun. 1970 Nov;2(5):556–562. doi: 10.1128/iai.2.5.556-562.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Granfors K., Toivanen A. IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis. Ann Rheum Dis. 1986 Jul;45(7):561–565. doi: 10.1136/ard.45.7.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gravallese E. M., Kantrowitz F. G. Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988 Jul;83(7):703–709. [PubMed] [Google Scholar]
  24. Hawkey C. J. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ. 1990 Feb 3;300(6720):278–284. doi: 10.1136/bmj.300.6720.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Inman R. D., Johnston M. E., Klein M. H. Analysis of serum and synovial fluid IgA in Reiter's syndrome and reactive arthritis. Clin Immunol Immunopathol. 1987 May;43(2):195–203. doi: 10.1016/0090-1229(87)90127-9. [DOI] [PubMed] [Google Scholar]
  26. Jertborn M., Svennerholm A. M., Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol. 1986 Aug;24(2):203–209. doi: 10.1128/jcm.24.2.203-209.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Katz K. D., Hollander D. Intestinal mucosal permeability and rheumatological diseases. Baillieres Clin Rheumatol. 1989 Aug;3(2):271–284. doi: 10.1016/s0950-3579(89)80021-4. [DOI] [PubMed] [Google Scholar]
  28. Kaufmann H. J., Taubin H. L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med. 1987 Oct;107(4):513–516. doi: 10.7326/0003-4819-107-4-513. [DOI] [PubMed] [Google Scholar]
  29. Kent T. H., Cardelli R. M., Stamler F. W. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol. 1969 Feb;54(2):237–249. [PMC free article] [PubMed] [Google Scholar]
  30. Krugliak P., Hollander D., Le K., Ma T., Dadufalza V. D., Katz K. D. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs. Gut. 1990 Apr;31(4):417–421. doi: 10.1136/gut.31.4.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Langman M. J., Morgan L., Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed) 1985 Feb 2;290(6465):347–349. doi: 10.1136/bmj.290.6465.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Madhok R., MacKenzie J. A., Lee F. D., Bruckner F. E., Terry T. R., Sturrock R. D. Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med. 1986 Jan;58(225):53–58. [PubMed] [Google Scholar]
  33. Marks J. S., Gleeson M. H. Steatorrhoea complicating therapy with mefenamic acid. Br Med J. 1975 Nov 22;4(5994):442–442. doi: 10.1136/bmj.4.5994.442-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mestecky J., McGhee J. R., Arnold R. R., Michalek S. M., Prince S. J., Babb J. L. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest. 1978 Mar;61(3):731–737. doi: 10.1172/JCI108986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mestecky J., McGhee J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153–245. doi: 10.1016/s0065-2776(08)60240-0. [DOI] [PubMed] [Google Scholar]
  36. Mestecky J., McGhee J. R., Michalek S. M., Arnold R. R., Crago S. S., Babb J. L. Concept of the local and common mucosal immune response. Adv Exp Med Biol. 1978;107:185–192. doi: 10.1007/978-1-4684-3369-2_22. [DOI] [PubMed] [Google Scholar]
  37. Mielants H., Veys E. M., Cuvelier C., de Vos M. Ileocolonoscopic findings in seronegative spondylarthropathies. Br J Rheumatol. 1988;27 (Suppl 2):95–105. doi: 10.1093/rheumatology/xxvii.suppl_2.95. [DOI] [PubMed] [Google Scholar]
  38. Park H., Schumacher H. R., Zeiger A. R., Rosenbaum J. T. Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology? Ann Rheum Dis. 1984 Oct;43(5):725–728. doi: 10.1136/ard.43.5.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pease C. T., Fordham J. N., Stubbs M. M., Archer J. R. IgA antibodies to gram-negative bacteria in the serum and saliva of patients with ankylosing spondylitis. Scand J Rheumatol. 1987;16(3):199–203. doi: 10.3109/03009748709165274. [DOI] [PubMed] [Google Scholar]
  40. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 1979 Oct;77(4 Pt 1):761–767. [PubMed] [Google Scholar]
  41. Rooney P. J., Jenkins R. T., Smith K. M., Coates G. 111Indium-labelled polymorphonuclear leucocyte scans in rheumatoid arthritis--an important clinical cause of false positive results. Br J Rheumatol. 1986 May;25(2):167–170. doi: 10.1093/rheumatology/25.2.167. [DOI] [PubMed] [Google Scholar]
  42. Sanders K. M., Hertzman A., Escobar M. R., Littman B. H. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis. 1987 Apr;46(4):273–276. doi: 10.1136/ard.46.4.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sartor R. B. Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases. Baillieres Clin Rheumatol. 1989 Aug;3(2):223–245. doi: 10.1016/s0950-3579(89)80019-6. [DOI] [PubMed] [Google Scholar]
  44. Satoh H., Guth P. H., Grossman M. I. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology. 1983 Mar;84(3):483–489. [PubMed] [Google Scholar]
  45. Saverymuttu S. H., Peters A. M., Lavender J. P., Hodgson H. J., Chadwick V. S. 111Indium autologous leucocytes in inflammatory bowel disease. Gut. 1983 Apr;24(4):293–299. doi: 10.1136/gut.24.4.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Scott D. L. Clinical measurements in rheumatology. Br J Rheumatol. 1987 Apr;26(2):81–83. doi: 10.1093/rheumatology/26.2.81. [DOI] [PubMed] [Google Scholar]
  47. Segal A. W., Isenberg D. A., Hajirousou V., Tolfree S., Clark J., Snaith M. L. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol. 1986 May;25(2):162–166. doi: 10.1093/rheumatology/25.2.162. [DOI] [PubMed] [Google Scholar]
  48. Smith M. D., Gibson R. A., Brooks P. M. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol. 1985 Apr;12(2):299–305. [PubMed] [Google Scholar]
  49. Stodell M. A., Butler R. C., Zemelman V. A., Henry K., Brewerton D. A. Increased numbers of IgG-containing cells in rectal lamina propria of patients with ankylosing spondylitis. Ann Rheum Dis. 1984 Apr;43(2):172–176. doi: 10.1136/ard.43.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Trull A. K., Ebringer R., Panayi G. S., Colthorpe D., James D. C., Ebringer A. IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis. Scand J Rheumatol. 1983;12(3):249–253. doi: 10.3109/03009748309098543. [DOI] [PubMed] [Google Scholar]
  51. Trull A., Ebringer A., Panayi G., Ebringer R., James D. C. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol. 1984 Jan;55(1):74–80. [PMC free article] [PubMed] [Google Scholar]
  52. Ukabam S. O., Clamp J. R., Cooper B. T. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion. 1983;27(2):70–74. doi: 10.1159/000198932. [DOI] [PubMed] [Google Scholar]
  53. Wands J. R., LaMont J. T., Mann E., Isselbacher K. J. Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med. 1976 Jan 15;294(3):121–124. doi: 10.1056/NEJM197601152940301. [DOI] [PubMed] [Google Scholar]
  54. Westedt M. L., Daha M. R., Baldwin W. M., 3rd, Stijnen T., Cats A. Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis. Ann Rheum Dis. 1986 Oct;45(10):809–815. doi: 10.1136/ard.45.10.809. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES